AXTA

Anderson Carl Douglas II

Known title: SVP and CFOCIK: 0001770503

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 6, 2026

UBS Cuts Axalta Price Target to $36, Maintains Neutral Rating. UBS lowered its price target for Axalta to $36 while keeping a neutral stance. The company also announced the date for its third-quarter 2026 earnings call. These updates provide new context as Axalta trades near its 52-week low, with the stock currently sitting above a key support level.

this person other insiders at AXTA

Transaction History

AXTA▲ Buy—
AXTA▼ Sell$354K
AXTA▲ Buy—
AXTA▼ Sell$98K
AXTA▼ Sell$402K
AXTA▲ Buy—
AXTA▼ Sell$732K
AXTA▲ Buy—
AXTA▼ Sell$101K
AXTA▲ Buy—
AXTA▲ Buy—
AXTA▼ Sell$290K
AXTA▲ Buy—
AXTA▼ Sell$104K
AXTA▲ Buy—
AXTA▼ Sell$306K

We use analytics to understand how market-wall is used. No personal data is sold.